Clinical Trial Update: Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome [Phase 4]

View source ↗

Summary

This Phase 4 trial compares posaconazole to micafungin for preventing invasive fungal infections during neutropenia in patients receiving chemotherapy for acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Mycamine (Micafungin)
• NOXAFIL (POSACONAZOLE)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2017-07-24